scholarly journals Odds Ratio: Reflexão sobre a Validade de uma Medida de Referência em Epidemiologia

2013 ◽  
Vol 26 (5) ◽  
pp. 505
Author(s):  
Pedro Aguiar ◽  
Baltazar Nunes

Introduction: It is very important to review the meaning of the Odds Ratio as a measure of effect and association, as well as, the bias of the Odds Ratio when it is assumed as a risk ratio or a prevalence ratio in the case of frequent disease or frequent health outcome.Material and Methods: We simulated in a cohort of 200 individuals with 100 exposed and 100 non-exposed to a risk factor, a first setting of rare disease and a second setting of a more frequent disease. In both settings the risk ratios were similar. We computed the Odds Ratio and Relative Risks by the classical approach (standard method) and respectively by logistic regression and Poisson regression. After these, we introduced in the cohort a confounding variable and then we computed the Odds Ratio and Relative Risk by Mantel-Hanszel stratified analysis (standard method) and respectively by multiple logistic regression and multiple Poisson regression.We used the 95% confidence interval in parameter estimation and SPSS V20 was used in statistical analysis.Results: In the case of rare disease the Odds Ratio was very close to the Relative Risk. For more frequent disease the Odds Ratio overestimated the Relative Risk. In this situation and with a confounding variable, the relative Risk adjusted by Poisson regression was more valid then the Odds Ratio to represent a risk ratio. The confidence intervals of the Relative Risk adjusted by Poisson regression were always greater than Mantel-Hanszel confidence intervals.Conclusions: The Odds Ratio and multiple logistic regression were valid analytic procedures in several epidemiological designs such as case-control studies and exploratory prospective studies as well as exploratory cross-sectional studies. The Odds Ratio should not be interpreted as a risk ratio or a prevalence ratio in the case of a health outcome that it is not rare. The multiple Poisson regression should be considered as an alternative procedure to logistic regression, especially if we want to estimate the effect of a specific exposure to a risk factor.

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 4211-4211
Author(s):  
Sarah A Bennett ◽  
Lara N Roberts ◽  
Rosie Rogers ◽  
Lynda Bonner ◽  
Raj K Patel ◽  
...  

Abstract Abstract 4211 Platelet size is thought to reflect reactivity; Mean platelet volume (MPV) was recently reported as a possible predictor for VTE, but it is not clear whether ethnic origin impacts on this risk factor. King's serves an ethnically diverse community and to assess whether MPV is a predictor of VTE in our population, we conducted a retrospective analysis of consecutive patients referred to our DVT service between January 2007 and October 2009. Patients with a confirmed first lower limb DVT (provoked n=153, unprovoked n=110) were included as subjects and controls (n=151) were derived from consecutive patients referred with objective exclusion of a DVT and no previous history of VTE, active cancer or surgery in the previous 6 weeks. All patients had a full blood count at presentation analysed on an automated analyser (using optical light scatter for MPV) within 4 hours of collection. There was no difference in mean age (54.7 vs 54.8), smoking status or ethnic group (51% vs 52.3% white, 38.4% vs 33.8% black and 10.6% vs 13.9% other) between subjects and controls respectively. Males accounted for 47.5% of subjects and 27.2% of controls. DVTs were unprovoked in 41.8% with 13.7% associated with surgery, 7.6% cancer, 10.6% pregnancy or hormone therapy. The remainder (25.1%) were secondary to cast, trauma, immobilisation or travel. Mean MPV was significantly higher in subjects than controls (8.17 vs 7.79, p=0.001) with a more marked difference in those with unprovoked DVT compared with controls (8.28 vs 7.79, p<0.001). The platelet count was lower in the DVT group (median, range 270, 21–812 vs 293, 31–642 p=0.027), with a more marked difference in those with unprovoked DVT (median, range 250, 21–584 vs 293, 31–642 p<0.001). Relative risk associated with MPV > 9.18 (90th centile) was 1.26 (95% CI 1.08– 4.76, p=0.01) and increased to 1.59 (1.18-2.1, p=0.008) in those with unprovoked DVT. Relative risk associated with platelet count <210 (10th centile) was 1.21 (1.02-1.43, p=0.06) and increased with unprovoked DVT to 1.70 (1.3-2.2, p=0.002). An inverse correlation between MPV and platelet count was confirmed (-0.305, p<0.001). Logistic regression was undertaken to investigate effect of MPV, platelet count, age and smoking status. MPV was the only significant risk factor for DVT with odds ratio 1.39 (1.14-1.68). For unprovoked DVT, both MPV and platelet count contributed to risk with odds ratio of 1.36 (1.06-1.74, p=0.015) and 0.997 (0.994-1.0, p=0.037) respectively. Further analysis was undertaken to compare MPV in white (provoked 84, unprovoked 50, controls 79) and black (provoked 55, unprovoked 46, controls 51) subgroups. There was no difference in mean age between white and black subjects or controls. Interestingly, in the black subgroup 73.9% of males had an unprovoked DVT compared with 26.1% of females. This gender difference was not seen in the white subgroup (unprovoked 37.9% males, 36.8% females) and was not explained by the presence of pregnancy or hormone use (18 vs 18.4% black vs white females). There was no significant difference in MPV or platelet count between white and black subjects or white and black controls. There remained a significant difference between white subjects and white controls mean MPV (8.1 vs 7.7, p=0.014) accentuated in the unprovoked subgroup (8.3 vs7.7, P=0.007); median platelet count was only significantly lower for unprovoked DVT compared to controls (251.5, 21–509 vs 285, 31–687, p=0.02). MPV was also significantly higher in black subjects compared to controls (8.3 vs 7.8, p=0.011), and platelet count was significantly lower (256, 129–811 vs 293, 138–642 p=0.032). MPV was no different between unprovoked DVTs and controls, however the effect of platelet count was accentuated (244.5, 167–584 vs 293, 138–642 p<.001). Logistic regression confirmed male gender as the only predictive factor for unprovoked VTE in the black subgroup (OR 5.8, 95% CI 2.36–14, p<0.001); neither MPV nor platelet count contributed to DVT risk. Limitations include the retrospective nature of the study, number of subjects, unavailable body mass indices and the discrepant gender distribution between controls and subjects. In summary, MPV is a risk factor for DVT in both white and black populations, though this link appears to hold true for unprovoked DVT in white populations only. Disclosures: No relevant conflicts of interest to declare.


1994 ◽  
Vol 112 (3) ◽  
pp. 569-577 ◽  
Author(s):  
J. C. Butler ◽  
M. E. Proctor ◽  
K. Fessler ◽  
D. J. Hopfensperger ◽  
D. M. Sosin ◽  
...  

SUMMARYStudies from developing countries suggest that persons with household-acquired (HA) measles are at greater risk of severe illness than persons with community acquired (CA) infection. Reported measles cases occurring among Milwaukee residents from May 1989 to June 1990 were used to assess whether household acquisition was a risk factor for severe measles in the United States. A case was classified as HA if onset of rash occurred 7–18 days after onset of rash in another case in the same household. Hospitalization rates were similar for 128 patients with HA measles (27%) and for 1004 patients with CA measles (26%). Multiple logistic regression was used to evaluate the association between hospitalization and household-acquisition after controlling for socioeconomic status, measles vaccination history, age, race, and date of onset of rash. Patients with HA measles were no more likely to be hospitalized than patients with CA measles (odds ratio 0·9, 95% confidence interval 0·6, 1·5). HA measles cases were not more severe than CA measles cases during this urban outbreak in the United States.


2014 ◽  
Vol 30 (1) ◽  
pp. 21-29 ◽  
Author(s):  
Suzi Alves Camey ◽  
Vanessa Bielefeldt Leotti Torman ◽  
Vania Naomi Hirakata ◽  
Renan Xavier Cortes ◽  
Alvaro Vigo

Recent studies have emphasized that there is no justification for using the odds ratio (OR) as an approximation of the relative risk (RR) or prevalence ratio (PR). Erroneous interpretations of the OR as RR or PR must be avoided, as several studies have shown that the OR is not a good approximation for these measures when the outcome is common (> 10%). For multinomial outcomes it is usual to use the multinomial logistic regression. In this context, there are no studies showing the impact of the approximation of the OR in the estimates of RR or PR. This study aimed to present and discuss alternative methods to multinomial logistic regression based upon robust Poisson regression and the log-binomial model. The approaches were compared by simulating various possible scenarios. The results showed that the proposed models have more precise and accurate estimates for the RR or PR than the multinomial logistic regression, as in the case of the binary outcome. Thus also for multinomial outcomes the OR must not be used as an approximation of the RR or PR, since this may lead to incorrect conclusions.


2020 ◽  
Vol 32 (2) ◽  
pp. 344-347
Author(s):  
Suresh Kumar Sharma ◽  
Shiv Kumar Mudgal ◽  
Jitender Chaturvedi

Relative risk and odds ratio are commonly used in the biomedical research studies; however, expression and interpretation must be done very carefully. A risk ratio and an odds ratio are used in cohort studies but only odds ratio is used in case control studies. However, relative risk or risk ratio is found to be frequently used in the interventional biomedical research studies. The relative risk and odds ratio provide important information regarding the effect of a risk factor on the outcome of interest. The relative risk and odds ratio of 1 suggests that there is no difference between two groups. A value >1 suggests increase risk, while a value <1 suggest reduction of risk. If the confidence interval meets or includes value 1.00 (line of no difference) indicates there is no difference between the groups.


2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Yuta Tezuka ◽  
Adina Turcu

Abstract Background: Medical treatment with mineralocorticoid receptor antagonists (MRAs) is preferred for patients with primary aldosteronism (PA) who are not surgical candidates. Adequate mineralocorticoid receptor blockade, as suggested by renin elevation above suppression levels, has been associated with lower rates of cardiovascular and renal complications as compared with PA with sustained renin suppression. Objectives: To assess the timeline and rates of achieving target renin levels in patients with PA and low renin hypertension treated with MRAs. Patients and Methods: We conducted a retrospective cohort study of adult patients with hypertension who were treated with MRAs in an academic center between 2003-2019. Of these, we included patients who had suppressed renin at baseline, and repeated renin measurement(s) during MRAs therapy. Renin suppression was defined as plasma renin activity (PRA) 1.0 ng/mL/h or direct renin concentration (DRC) 8.0 pg/mL. We excluded patients with adrenal cancer, end-stage renal disease, exogenous glucocorticoids, and critically ill. Mann-Whitney test, Wilcoxon signed rank test, Chi-Square test and multiple logistic regression analysis were employed, as appropriate. Results: So far, 89 patients (45 men), median age 56 (range, 19-84), have been included. Of these, 46% had confirmed PA; 25% had positive PA screening, but no confirmatory tests; and 29% had other forms of low-renin hypertension. On average, patients were on 2.9 1.6 antihypertensive agents; 62% of patients were prescribed beta blockers, and 38% were on K+ supplements. Overall, renin (PRA in 69 cases, and DRC in 20 cases) increased after MRA treatment (from 0.40 [0.10, 0.60] ng/mL/h to 1.10 [0.60, 2.23] ng/mL/h; and from 2.1 [2.1, 3.7] pg/mL to 5.7 [2.9, 16.7] pg/mL, respectively, p&lt;0.0001 for both). The cumulative proportions of patients in whom renin reached target levels during MRA treatment were: 25% at 2 weeks; 38.9% at 1 month; 34.2% at 3 months; 39.5% at 6 months; and 47.2% at 1 year. Age, sex, race, blood pressure, use of beta blockers, renal function, serum K+ and aldosterone concentrations were similar between patients with target vs. suppressed renin. Multiple logistic regression analysis suggested that after adjusting for age and sex, higher MRA dose and higher BMI were associated with higher likelihood of achieving target renin during MRA therapy (odds ratio (95%CI): 1.021 (1.001-1.041) and 1.097 (1.008-1.193), respectively, p&lt;0.05 for both); conversely, beta blockers use tended to be less often associated with target renin (odds ratio, 0.37 (0.13-1.008), p=0.052). Conclusion: Although raising renin above suppression levels is important for reducing the cardiovascular risk associated with PA, this goal is achieved in less than half of patients, even after one year of treatment with MRAs, in an academic setting. Strategies for optimizing PA treatment are critically needed.


1997 ◽  
Vol 118 (3) ◽  
pp. 243-252 ◽  
Author(s):  
P. F. SMITH ◽  
J. C. GRABAU ◽  
A. WERZBERGER ◽  
R. A. GUNN ◽  
H. R. ROLKA ◽  
...  

An Hasidic Jewish community has experienced recurrent hepatitis A outbreaks since 1980. To assess risk factors for illness during a 1985–6 outbreak, the authors reviewed case records and randomly selected 93 households for an interview and serologic survey. In the outbreak, 117 cases of hepatitis A were identified, with the highest attack rate (4·2%) among 3–5 year olds. Among the survey households, the presence of 3–5 year olds was the only risk factor that increased a household's risk of hepatitis A (indeterminant relative risk, P=0·02). Furthermore, case households from the outbreak were more likely to have 3–5 year olds than were control households from the survey (odds ratio=16·4, P<0·001). Children 3–5 years old were more likely to have hepatitis A and may have been the most frequent transmitters of hepatitis A in this community. Hepatitis A vaccination of 3–5 year olds can protect this age group and might prevent future outbreaks in this community.


2020 ◽  
Author(s):  
Werayuth Srithum ◽  
Mai Kabayama ◽  
Yasuyuki Gondo ◽  
Yukie Masui ◽  
Yuya Akagi ◽  
...  

Abstract Background: Cognitive impairment is a major health concern among older and oldest people.Moreover, stroke is a relevant contributor for cognitive decline and development of dementia. The study of cognitive decline focused on stroke as the important risk factor by recruiting older and oldest is still lagging behind. Therefore, the aim of this study was to investigate the importance of stroke as a risk factor of cognitive decline during three years in community dwelling older and oldest people. Methods: This study was longitudinal study with a 3-year follow-up in Japan. The participants were 1,333community dwelling older and oldest people (70 years old = 675, 80 years old = 589, and 90 years old = 69). Data collected included basic data (age, sex, and history of stroke), vascular risk factors (hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, and current smoking), and social factors (educational level, frequency of going outdoors, long-term care (LTC) service used, and residential area). The Japanese version of the Montreal Cognitive Assessment (MoCA-J) was decline of ≥ 2 points was defined as cognitive decline. Multiple logistic regression analysis was used to investigate the association between stroke and other risk factors with cognitive decline during a 3-year follow-up. Results: The fit of the hypothesized model by multiple logistic regression showed that a history of stroke, advanced age, and greater MoCA-J score at the baseline were important risk factors, while the presence of dyslipidemia and a higher educational level were protective factors that were significantly correlated with cognitive decline during the 3-year follow-up. Conclusions: The cognitive decline after the 3-year follow-up was influenced by the history of stroke and advanced age, while greater MoCA-J score at the baseline was positively associated with subsequent 3 years cognitive decline. The protective factors were the presence of dyslipidemia and a higher educational level. Therefore, these factors are considered important and should be taken into consideration when searching for creative solutions to prevent cognitive decline after stroke in community dwelling older and oldest people.


Stroke ◽  
2021 ◽  
Author(s):  
Jacqueline H. Geer ◽  
Guido J. Falcone ◽  
Kevin N. Vanent ◽  
Audrey C. Leasure ◽  
Daniel Woo ◽  
...  

Background and Purpose: To determine whether obstructive sleep apnea (OSA) is associated with intracerebral hemorrhage (ICH) risk, we assessed premorbid OSA exposure of patients with nontraumatic ICH and matched controls. Methods: Ethnic/Racial Variations of Intracerebral Hemorrhage is a multicenter, case-control study evaluating risk factors for ICH that recruited 3000 cases with ICH and 3000 controls. OSA status was ascertained using the Berlin Questionnaire as a surrogate for premorbid OSA. We performed logistic regression analyses to evaluate the association between OSA and ICH. Results: Two thousand and sixty-four (71%) cases and 1516 (52%) controls were classified as having OSA by the Berlin Questionnaire. Cases with OSA were significantly more likely to be male and have hypertension, heart disease, hyperlipidemia, and higher body mass index compared with those without OSA. OSA was more common among cases compared with controls (71% versus 52%, odds ratio, 2.28 [95% CI, 2.05–2.55]). In a multivariable logistic regression model, OSA was associated with increased risk for ICH (odds ratio, 1.47 [95% CI, 1.29–1.67]). Conclusions: OSA is a risk factor for ICH.


2019 ◽  
pp. 69-73
Author(s):  
Steve Selvin

Two often confused statistical techniques are the odds ratio and relative risk ratio. These basic statistics are discussed and illustrated by contrasting risks from an analysis of breast cancer incidence among military women who served in Vietnam.


Sign in / Sign up

Export Citation Format

Share Document